SMITH DAVID V (Executive Vice President & CFO) reported 1 transaction at FIVE PRIME THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/30/2020ACC: 0001209191-20-060707
Officer· Executive Vice President & CFO
Since Nov 2018
-6.92K
Net shares
Net seller
$127.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.92K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.92K
Price / share
$18.45
Trade value
$127.67K
% of position
9.3%
11/26/2020
74.48K→67.56K
Total
Net shares
−6.92K
Net value
-$127.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/26/2020 | F · Tax Withholding | −6.92K | $18.45 | $127.67K | 9.3% | 74.48K | 67.56K |
| Total | −6.92K | -$127.67K | ||||||
Derivative Transactions0
No derivative transactions reported